Gou Wen-Feng, Yang Xue-Feng, Shen Dao-Fu, Zhao Shuang, Sun Hong-Zhi, Luo Jun-Sheng, Zheng Hua-Chuan
Cancer Center, The First Affiliated Hospital of Liaoning Medical University, Jinzhou, Liaoning 121001, P.R. China.
Key Laboratory of Brain and Spinal Cord Injury of Liaoning Province, The First Affiliated Hospital of Liaoning Medical University, Jinzhou, Liaoning 121001, P.R. China.
Oncol Lett. 2017 Mar;13(3):1631-1636. doi: 10.3892/ol.2017.5632. Epub 2017 Jan 23.
The inhibitor of growth family, member 3 (ING3) protein may be capable of blocking the cell cycle via activating p53-transactivated promoters of p21 and Bcl2-associated X protein, and may induce apoptosis via a Fas/caspase-8-dependent signaling pathway. In the present study, immunohistochemistry was performed in order to characterize the expression profile of ING3 protein in tissue microarrays containing mouse and human normal tissue, human hepatocellular (n=62), renal clear cell (n=62), pancreatic (n=62), esophageal squamous cell (n=45), cervical squamous cell (n=31), breast (n=144), gastric (n=196), colorectal (n=96), ovarian (n=208), endometrial (n=96) and lung carcinoma (n=192). In mouse tissue, ING3 protein was positively detected in the cytoplasm of cardiomyocytes, kidney and skeletal muscle cells, and was additionally detected in the cytoplasm and nucleus of bronchial and alveolar epithelium, gastric and intestinal gland, and mammary gland cells. In human tissues, ING3 protein was principally distributed in the cytoplasm, but was observed in the cytoplasm and nucleus of tongue, esophagus, stomach, intestine, lung, skin, appendix, bladder, cervix and breast cells. ING3 immunoreactivity was strongly detected in the stomach, skin and cervical tissues, whereas a weak signal was detected in the cerebellum, brain stem, thymus, liver, skeletal muscle, testis and prostate. In total, ING3-positive specimens were identified in 424 of 1,194 tested cancer entities (35.5%). In a number of cases, ING3 expression was observed to be restricted to the cytoplasm and nucleus, excluding the cytoplasmic distribution identified in breast and hepatocellular carcinoma. Among these cases, ING3 was more frequently expressed in breast and gynecological types of cancer, including ovarian (59.2%), endometrial (47.9%), breast (38.9%) and cervical (35.5%) cancer. ING3-positive cases were more rare in renal clear cell (17.7%), hepatocellular (16.1%) and esophageal carcinoma (17.8%). It is suggested that ING3 may be involved in the repair and regeneration of organs or tissues, and may be closely associated with gynecological carcinogenesis.
生长抑制家族成员3(ING3)蛋白可能能够通过激活p21和Bcl2相关X蛋白的p53反式激活启动子来阻断细胞周期,并可能通过Fas/半胱天冬酶-8依赖性信号通路诱导细胞凋亡。在本研究中,进行了免疫组织化学分析,以表征ING3蛋白在包含小鼠和人类正常组织、人类肝细胞癌(n = 62)、肾透明细胞癌(n = 62)、胰腺癌(n = 62)、食管鳞状细胞癌(n = 45)、宫颈鳞状细胞癌(n = 31)、乳腺癌(n = 144)、胃癌(n = 196)、结直肠癌(n = 96)、卵巢癌(n = 208)、子宫内膜癌(n = 96)和肺癌(n = 192)的组织微阵列中的表达谱。在小鼠组织中,ING3蛋白在心肌细胞、肾和骨骼肌细胞的细胞质中呈阳性检测到,并且在支气管和肺泡上皮、胃和肠腺以及乳腺细胞的细胞质和细胞核中也检测到。在人类组织中,ING3蛋白主要分布在细胞质中,但在舌、食管、胃、肠、肺、皮肤、阑尾、膀胱、宫颈和乳腺细胞的细胞质和细胞核中也观察到。在胃、皮肤和宫颈组织中强烈检测到ING3免疫反应性,而在小脑、脑干、胸腺、肝脏、骨骼肌、睾丸和前列腺中检测到微弱信号。在总共1194个测试的癌症实体中,有424个(35.5%)鉴定为ING3阳性标本。在一些病例中,观察到ING3表达仅限于细胞质和细胞核,不包括在乳腺癌和肝细胞癌中确定的细胞质分布。在这些病例中,ING3在乳腺癌和妇科癌症类型中更频繁表达,包括卵巢癌(59.2%)、子宫内膜癌(47.9%)、乳腺癌(38.9%)和宫颈癌(35.5%)。ING3阳性病例在肾透明细胞癌(17.7%)、肝细胞癌((16.1%)和食管癌(17.8%)中较少见。提示ING3可能参与器官或组织的修复和再生,并且可能与妇科肿瘤发生密切相关。